Reblozyl 75 mg, Pulver zur Herstellung einer Injektionslösung

7680695920024 CH-69592 Pulver

No image available

Article details

Package size
1 x 75 mg
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/07/2026
Summary of Product Characteristics
Français
09/07/2026
Summary of Product Characteristics
Italien
09/07/2026

Detailed composition

Substance Quantity Type Category
luspaterceptum
75.0 MG Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
saccharum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
69592
Drug name
Reblozyl, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
B03XA06
Authorization status
Z
Dispensing category
A
First authorization
21/05/2026
Authorization expiration date
20/05/2031
IT Number
06.07.3.
Domain
Human medicine
Field of application
Myelodysplastische Syndrome, β-Thalassämie

Package details

Description (FR)
REBLOZYL subst seche 75 mg 1x75mg pce
Description (DE)
REBLOZYL Trockensub 75 mg 1x75mg Stk
Market launch
30/06/2026
Narcotic (BTM)
No

Other package sizes (1)

REBLOZYL subst seche 25 mg 1x25mg pce
1 x 25 mg DUR
GTIN: 7680695920017
View
Buy us a coffee Explore the data